NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC6125270/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC6125270/. The analysis below is for the second page.

Title[redir]:
Synergistic effect of metformin on sorafenib in in vitro study using hepatocellular carcinoma cell lines - PMC
Description:
Hepatocellular carcinoma (HCC) recurrence remains a great concern following hepatic resection and liver transplantation. We investigated the metformin-induced cytotoxic effects on sorafenib in an in vitro study using HCC cell lines. This research ...

Matching Content Categories {📚}

Education
Science
Social Networks

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 6,399,052 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't figure out the monetization strategy.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Ncbi.nlm.nih.gov could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

metformin, sorafenib, cell, doi, study, effects, tumor, hcc, pubmed, google, scholar, synergistic, vitro, patients, cancer, hepatocellular, carcinoma, lines, antitumor, liver, advanced, fig, pmc, effect, apoptosis, survival, assays, nlm, revealed, expression, clinical, line, xenograft, cells, rtpcr, cytotoxic, patientderived, hbx, administration, mtor, pathway, protein, ampk, res, ncbi, search, kim, hepg, results, risk,

Topics {✒️}

6-diamidino-2-phenylindole-hoechst staining hepato-biliary-pancreatic surgery amp-activated protein kinase tumor necrosis factor-α rag gtpase-dependent manner pmc beta search drug-treated cells relative rapamycin-dependent translation initiation median progression-free survival metformin-induced cytotoxic effects patient-derived xenograft inhibit hbv-derived hcc population-based cohort study lc3-ii assays revealed publisher site pdf generation xenograft tumor cell-cycle arrest license information pmcid advanced hepatocellular carcinoma hcc cell lines recurrent hepatocellular carcinoma hepatocellular carcinoma cells noticeable synergistic effect vitro drug concentrations increased tumor aggressiveness anti-tumor effect dose-dependent manner experience tumor progression antitumor effects revealed line chemotherapeutic agent kras-mutant advanced statistically significant difference acknowledgements disclosure methods study design synergistic cytotoxic effect human hcc tissue chronic liver disease concentration-dependent decrease tnf-α revealed united states government randomized controlled trials polyacrylamide gel electrophoresis asia-pacific region phase iii randomised placebo-controlled trial le marchand-brustel van der burg expert opin pharmacother treating advanced hcc established cell line

Social Networks {👍}(6)

External Links {🔗}(53)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.04s.